logo

Brian Armstrong’s NewLimit Raises $130 Million for Anti-Aging Research

By: bitdegree|2025/05/07 15:30:02
0
Share
copy
Ace quick missions & earn crypto rewards while gaining real-world Web3 skills. Participate Now ! A biotech company co-founded by Coinbase $1.58B CEO Brian Armstrong, NewLimit , has secured $130 million in new funding . The funding round, called Series B, was led by Kleiner Perkins , according to a May 6 statement . New investors joining in this round include former GitHub CEO Nat Friedman, Daniel Gross, who used to lead machine learning efforts at Apple, and Khosla Ventures. Did you know? Subscribe - We publish new crypto explainer videos every week! What is Solana in Crypto? (Beginner-Friendly Animation) SUBSCRIBE Armstrong started NewLimit with Blake Byers, a former GV partner, and stem cell researcher Jacob Kimmel. The company is working on therapies that aim to extend the number of healthy years a person can live . The approach focuses on changing how cells work by adjusting the epigenome, which affects cell behavior without altering the DNA. NewLimit believes that aging is not just a natural process but a key factor behind many major diseases. The company explained that while aging was once thought to be permanent, new research in epigenetic reprogramming suggests it can be changed. The company uses a combination of genomics and artificial intelligence (AI) . Its main tool, called the Discovery Engine , tests thousands of ways to adjust human cells and studies the results . Machine learning models then help decide which changes to test next. In a statement, NewLimit stated, "Our bet is that this combination of AI and scaled genomics can unlock medicines that give each of us more healthy years". Recently, Neuralink, the brain tech company founded by Elon Musk, invited people to participate in its global brain chip trials. What is the aim of the trial? Read the full story . Enjoyed this article? Share it with your friends!

You may also like

6MV Founder: In 2026, the "landmark turning point" for crypto investment has arrived

"I will deploy funds in 2026, so I will tell you this is the best year in history."

Abraxas Capital Mints $2.89 Billion USDT: Liquidity Boost or Just More Stablecoin Arbitrage?

Abraxas Capital just received $2.89 billion in freshly minted USDT from Tether. Is this a bullish liquidity injection for crypto markets, or is it business as usual for a stablecoin arbitrage giant? We analyze the data and the likely impact on Bitcoin, altcoins, and DeFi.

A VC from the Crypto world said AI is too crazy, and they are very conservative

Amid the Crypto frenzy and with investors who once missed out on Pinduoduo, a new AI fund called Impa Ventures was established, rejecting bubble narratives and adhering to a conservative "problem-first" strategy to seek real business value.

The Evolutionary History of Contract Algorithms: A Decade of Perpetual Contracts, the Curtain Has Yet to Fall

The ten-year evolution of perpetual contracts: from pulling the plug on 312 to the shocking short squeeze of TRB, a deep dive into the pricing machine that averages $200 billion daily, written with countless liquidations and real money, detailing the blood and tears of risk control theory.

Kicked out by PayPal, Musk aims to make a comeback in the cryptocurrency market

Cashtags generated a trading volume of 1 billion dollars just a few days after its launch, marking a strong start for Musk's super app strategy. For the cryptocurrency market, X's layout may be one of the most anticipated sources of retail growth after the meme coin craze subsides.

Solana ETF News: What Is a Solana ETF and Why Is Goldman Sachs Betting $108 Million on SOL?

Solana ETF news today shows Goldman Sachs disclosed a $108M position while total SOL ETF inflows reached $1.45B. Analysts now expect up to $6B in institutional demand as Solana trades 71% below its all-time high.

Popular coins

Latest Crypto News

Read more